SCHEMBL6387882

SCHEMBL6387882

O=C(CCNC(=O)OCc1ccc(-c2ccccc2)cc1)NO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
LMNA P02545 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HDAC2 Q92769 3/20 0.55
HDAC1 Q13547 6/20 0.54
MMP3 P08254 1/20 0.51
MMP2 P08253 2/20 0.51
MMP9 P14780 2/20 0.51
EPHX1 P07099 1/20 0.51
PRSS1 P07477 1/20 0.50
TPSAB1 Q15661 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
FOLH1 Q04609 1/20 0.49
HDAC6 Q9UBN7 5/20 0.49
MAPT P10636 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6386283 0.87 ALDH1A1 (0.53) HTTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL32681311 0.81 HTT (0.71) HTTLMNASMN1; SMN2HDAC2HDAC1
SCHEMBL6384837 0.81 HDAC1 (0.62) HTTMEN1KMT2ALMNAHDAC2
SCHEMBL14729295 0.80 HTT (0.69) HTTLMNASMN1; SMN2HDAC2HDAC1
SCHEMBL27860862 0.80 HTT (0.69) HTTLMNASMN1; SMN2HDAC2HDAC1
SCHEMBL5314068 0.79 HTT (0.64) HTTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL7514786 0.79 HTT (0.73) HTTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6431191 0.79 HTT (0.64) HTTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL17079191 0.79 HTT (0.64) HTTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL2573590 0.79 MGLL (0.63) MEN1KMT2AHDAC2HDAC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US claimed
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119305-A1 Il-6 production inhibitors IL6, IL6ST, PADI6 HTT 3197/4885MEN1 253/4885KMT2A 829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.